Insulin resistance is a cause of steatosis and fibrosis progression in chronic hepatitis C

بواسطة Fartoux, L, Poujol-Robert, A, Guéchot, J, Wendum, D, Poupon, R, Serfaty, L
منشور في 2005

Gemcitabine and oxaliplatin in advanced biliary tract carcinoma: a phase II study

بواسطة André, T, Reyes-Vidal, J M, Fartoux, L, Ross, P, Leslie, M, Rosmorduc, O, Clemens, M R, Louvet, C, Perez, N, Mehmud, F, Scheithauer, W
منشور في 2008

A multicentre, open-label, phase-I/randomised phase-II study to evaluate safety, pharmacokinetics, and efficacy of nintedanib vs. sorafenib in European patients with advanced hepat...

بواسطة Palmer, D. H., Ma, Y. T., Peck-Radosavljevic, M., Ross, P., Graham, J., Fartoux, L., Deptala, A., Studeny, M., Schnell, D., Hocke, J., Loembé, A-B., Meyer, T.
الحاوية / القاعدة Br J Cancer (2018)